文献速递临床微生物临床免疫

β-1,3-D-葡聚糖与半乳甘露聚糖检测侵袭性地霉与巨霉感染的回顾性评价

β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive Geotrichum and Magnusiomyces Infections: a Retrospective Evaluation.
PubMed 文献 · J Clin Microbiol · 2021-10-20

23例有血清样本者中BDG灵敏度65%、特异度96%,GM均为阴性、特异度100%,体外实验证实M. capitatus分泌大量BDG但不分泌GM。

要点

  • 巨霉/地霉感染不限于血液肿瘤患者,腹腔感染多有腹部手术史。
  • BDG检测灵敏度65%、特异度96%,与念珠菌血症相当。
  • GM检测在侵袭性巨霉感染中均为阴性,体外实验亦不分泌GM。

核心结论

  • GM不是诊断巨霉感染的合适生物标志物,与现行ESCMID/ECMM推荐相反;BDG灵敏度与念珠菌血症相当。

研究设计与样本

  • 对血清样本和培养上清采用两种市售真菌抗原检测(Platelia Aspergillus Ag EIA和Wako β-glucan test)进行分析。

主要发现

  • 23例有血清样本(14例血流感染、9例腹腔感染)中,BDG灵敏度65%,GM无一例阳性。
  • 体外实验显示M. capitatus分泌大量BDG但不分泌GM。
  • BDG特异度96%,GM特异度100%。

关键数值与推荐

  • BDG灵敏度65%、特异度96%;GM特异度100%、血清均为阴性。
  • ESCMID/ECMM联合指南推荐GM和BDG作为M. capitatus感染的替代标志物。

临床怎么用

  • 对疑似侵袭性巨霉/地霉感染,BDG可作为辅助检测手段,但不应依赖GM检测。
  • 腹部手术史患者出现腹腔感染时应考虑地霉/巨霉可能,血液肿瘤患者出现血流感染时亦需警惕。

局限性

  • 回顾性单中心设计,血清样本仅23例,样本量有限。
  • 对照组为门诊梅毒检测样本,可能不代表目标人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnusiomyces and Geotrichum species are ascomycetous yeasts that can cause potentially life-threatening invasive fungal infections commonly referred to as geotrichosis. In this study, we aimed to estimate the incidence and mortality of these infections in a German tertiary care center. Furthermore, we evaluated the suitability of the fungal biomarkers galactomannan (GM) and β-1,3-d-glucan (BDG), which are both recommended as surrogate markers for Magnusiomyces capitatus infection by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) joint clinical guidelines for the diagnosis and management of rare invasive yeast infections for detection of invasive geotrichosis. Cases meeting the inclusion criteria for invasive Magnusiomyces/Geotrichum infection were retrospectively identified. Serum samples and culture supernatants were analyzed with two commercially available fungal antigen tests (Platelia Aspergillus Ag EIA and Wako β-glucan test). For a control cohort, outpatient samples sent for lues testing were included. Thirty-eight cases of Magnusiomyces/Geotrichum infection were identified over an 11-year observation period. In the majority of cases, the fungus was isolated from intra-abdominal specimens of patients with a history of abdominal surgery/procedures (n = 32). All cases of fungemia occurred exclusively in haemato-oncologic patients (n = 14). Thirty-day survival was 42% in the fungemia and 43% in the intra-abdominal geotrichosis group. Serum samples were available for 23 patients (14 bloodstream and nine intra-abdominal infections). While BDG sensitivity was 65%, none of the sera was GM positive. This finding was supported by in vitro experiments analyzing fungal culture supernatants: M. capitatus secretes significant amounts of BDG but not GM. Specificity was 96% for BDG and 100% for GM. Magnusiomyces and Geotrichum infections are not limited to haemato-oncologic patients. Contrasting the current ESCMID/ECMM recommendation, our results indicate that GM is no suitable biomarker for the diagnosis of Magnusiomyces infection. Contrarily, BDG sensitivity is comparable to that of candidemia.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Forster J, Koc Ö, Koeppel MB, et al. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive Geotrichum and Magnusiomyces Infections: a Retrospective Evaluation. J Clin Microbiol. 2021. PMID: 34669454. doi:10.1128/JCM.01607-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。